BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 931835)

  • 1. A method for testing the antibiotic susceptibility of Chlamydia trachomatis in a cell culture system.
    Ridgway GL; Owen JM; Oriel JD
    J Antimicrob Chemother; 1976 Mar; 2(1):71-6. PubMed ID: 931835
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative in vitro activity of RU 28965 against Chlamydia trachomatis.
    Cevenini R; Sambri V; La Placa M
    Eur J Clin Microbiol; 1986 Oct; 5(5):598-600. PubMed ID: 3536506
    [No Abstract]   [Full Text] [Related]  

  • 3. The antimicrobial susceptibility of Chlamydia trachomatis in cell culture.
    Ridgway GL; Owen JM; Oriel JD
    Br J Vener Dis; 1978 Apr; 54(2):103-6. PubMed ID: 638716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Techniques for culturing and determining antimicrobial susceptibility of Chlamydia trachomatis.
    Rota TR
    Arch Androl; 1980 Feb; 4(1):63-9. PubMed ID: 7356376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility of fifteen Chlamydia trachomatis strains isolated in Greece.
    Mentis AF; Tzouvelekis LS; Mavrommati L
    J Antimicrob Chemother; 1989 Jul; 24(1):94. PubMed ID: 2777733
    [No Abstract]   [Full Text] [Related]  

  • 6. Antibiotic susceptibility testing for Chlamydia trachomatis using flow cytometry.
    Dessus-Babus S; Belloc F; Bébéar CM; Poutiers F; Lacombe F; Bébéar C; de Barbeyrac B
    Cytometry; 1998 Jan; 31(1):37-44. PubMed ID: 9450523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzyme-linked immunosorbent assay for the in-vitro detection of sensitivity of Chlamydia trachomatis to antimicrobial drugs.
    Cevenini R; Donati M; Sambri V; Rumpianesi F; La Placa M
    J Antimicrob Chemother; 1987 Nov; 20(5):677-84. PubMed ID: 3323161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Methods of studying the sensitivity of Chlamydia trachomatis to antibiotics].
    Laurans G; Orfila J; Haider F
    Rev Int Trach Pathol Ocul Trop Subtrop Sante Publique; 1982; (2-3):93-106. PubMed ID: 7187965
    [No Abstract]   [Full Text] [Related]  

  • 9. Activity of antimicrobials against Chlamydia trachomatis in vitro.
    Ridgway GL; Oriel JD
    J Antimicrob Chemother; 1979 Jul; 5(4):483-4. PubMed ID: 489497
    [No Abstract]   [Full Text] [Related]  

  • 10. Antimicrobial drug susceptibility of 15 strains of Chlamydia trachomatis recently isolated from cases of non-gonococcal urethritis, in Italy.
    Cevenini R; Landini MP; Donati M; Rumpianesi F
    J Antimicrob Chemother; 1980 Mar; 6(2):294-6. PubMed ID: 7380774
    [No Abstract]   [Full Text] [Related]  

  • 11. Decreased susceptibility to azithromycin and doxycycline in clinical isolates of Chlamydia trachomatis obtained from recurrently infected female patients in India.
    Bhengraj AR; Vardhan H; Srivastava P; Salhan S; Mittal A
    Chemotherapy; 2010; 56(5):371-7. PubMed ID: 20938174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of the in vitro activity of various antibiotics against Chlamydia trachomatis by indirect immunoperoxidase method].
    Bannai H; Miyazawa H; Ashihara Y
    Kansenshogaku Zasshi; 1986 Oct; 60(10):1140-6. PubMed ID: 3100692
    [No Abstract]   [Full Text] [Related]  

  • 13. Activity of ofloxacin against Chlamydia trachomatis.
    Møller BR; Evans R; Kaspersen P; From E
    Drugs; 1987; 34 Suppl 1():181-3. PubMed ID: 3481321
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro activity of ciprofloxacin against Chlamydia trachomatis and Ureaplasma urealyticum.
    Rumpianesi F; Sambri V; Bertini S; Tamba I; Cevenini R
    Chemioterapia; 1984 Jun; 3(3):173-4. PubMed ID: 6529772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial susceptibility testing of Chlamydia trachomatis using a reverse transcriptase PCR-based method.
    Cross NA; Kellock DJ; Kinghorn GR; Taraktchoglou M; Bataki E; Oxley KM; Hawkey PM; Eley A
    Antimicrob Agents Chemother; 1999 Sep; 43(9):2311-3. PubMed ID: 10471587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Activity of a new quinoline derivative against Chlamydia trachomatis].
    Mitsui Y; Higashitsutsumi M
    Nippon Ganka Gakkai Zasshi; 1986 Aug; 90(8):1074-80. PubMed ID: 3464167
    [No Abstract]   [Full Text] [Related]  

  • 17. Activity of the newer quinolones against Chlamydia trachomatis.
    Van Roosbroeck RJ; Provinciael DR; Van Caekenberghe DL
    Br J Vener Dis; 1984 Oct; 60(5):350. PubMed ID: 6487989
    [No Abstract]   [Full Text] [Related]  

  • 18. [In vitro, activity of a new macrolide (RU 28965) against Chlamydia trachomatis and Ureaplasma urealyticum].
    Sambri V; Rumpianesi F; Franchi L; Cevenini R
    G Ital Chemioter; 1985; 32(1):175-6. PubMed ID: 3830774
    [No Abstract]   [Full Text] [Related]  

  • 19. Lack of mutation in macrolide resistance genes in Chlamydia trachomatis clinical isolates with decreased susceptibility to azithromycin.
    Bhengraj AR; Srivastava P; Mittal A
    Int J Antimicrob Agents; 2011 Aug; 38(2):178-9. PubMed ID: 21570258
    [No Abstract]   [Full Text] [Related]  

  • 20. In vitro activities of thirteen beta-lactam antibiotics against Chlamydia trachomatis.
    Muytjens HL; Heessen FW
    Antimicrob Agents Chemother; 1982 Sep; 22(3):520-1. PubMed ID: 7137988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.